Highlights
Maurice Wilkins Centre funding renewed (2014)
Maurice Wilkins Centre is one of two Centres for Research Excellence to have their funding renewed.
read the full story
Partnerships boost business: MWC supports Auckland Clinical Studies (2013)
The Maurice Wilkins Centre provides world-class support for medical trials provider Auckland Clinical Studies, helping to cement New Zealand’s growing reputation as a good place to
read the full story
New strategic alliance with China (2013)
Maurice Wilkins Centre investigators lead two research grants awarded in 2013 under the New Zealand-China Strategic Research Alliance (SRA).
read the full story
New Zealand TB drug candidate selected (2012)
In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidate by international non-profit drug developer the Global
read the full story
Rheumatic fever - Research strengths confront national need (2012)
The Maurice Wilkins Centre prioritises rheumatic fever research, and its work built momentum in 2012 with the appointment of a specialist researcher, funding of two research projec
read the full story
Creating connections with China (2012)
An official visit by State Councillor Liu Yandong, now a Vice-Premier of the People’s Republic of China, was the culmination of the Maurice Wilkins Centre’s work during 2012 to bui
read the full story
Drug selection a milestone for spin-out (2010)
In 2010 Maurice Wilkins Centre investigators Professors Bill Denny and Peter Shepherd selected a new anticancer drug candidate for clinical development, triggering US $4.5 million
read the full story
Creating connections between drug discovery and business (2009)
The Maurice Wilkins Centre hosted the New Zealand Drug Discovery Symposium in September 2009, bringing together more than 450 delegates from science, medicine, business, and ventur
read the full story
New Zealand patients trial local cancer drug (2012)
Cancer patients in Auckland, Waikato and the United States are participating in the first clinical trial of an exciting new drug invented in New Zealand.
read the full story
New drug targets treatment-resistant cancer (2011)
A new drug targeting an important group of cancer cells attracted international funding in 2011 and will soon enter clinical trials.
read the full story